Balance Sheet StrengthVery low leverage and a high equity ratio provide durable financial resilience. This capital structure supports operating flexibility, reduces bankruptcy risk in downturns, and preserves the capacity to fund R&D, capex, or selective M&A over the next 2-6 months without stressing liquidity.
Improving Cash GenerationA large improvement in free cash flow and strong cash conversion indicates sustainable internal funding. Persistent strong OCF relative to earnings allows investment in growth, debt reduction, or balance-sheet strengthening, making the business less reliant on external financing.
High Gross MarginsA ~61% gross margin reflects structurally favorable product economics and pricing power in medical instruments. Even if volumes fluctuate, high gross margins give room to cover fixed costs and support recovery of operating margins once revenue trends stabilize.